Is uterine artery embolization appropriate for a woman with large intramural fibroids who has failed a levonorgestrel intrauterine system and two months of dienogest therapy and continues to have heavy menstrual bleeding persisting to day 25?

Uterine Artery Embolization for Large Intramural Fibroids After Medical Therapy Failure

Uterine artery embolization is highly appropriate and should be offered as the next treatment step for this patient with large intramural fibroids who has failed both levonorgestrel IUD and dienogest therapy, given its proven efficacy in controlling heavy menstrual bleeding with clinical success rates of 81-100%. 1

Why UAE is Appropriate in This Clinical Scenario

Strong Evidence for Heavy Menstrual Bleeding Control

• UAE achieves 83% improvement in menorrhagia at 3 months post-procedure, making it highly effective for this patient's persistent bleeding to day 25. 1, 2
• The American College of Radiology guidelines specifically list heavy menstrual bleeding as a primary indication for UAE, regardless of fibroid size or number. 1
• Large registries with over 3,000 patients demonstrate 95% symptomatic relief at 12 months. 1, 2

Efficacy for Large Intramural Fibroids

• UAE achieves >50% average reduction in fibroid size at 5 years, with median fibroid volume reductions of 42% by 3 months. 1, 3, 2
• Retrospective studies show no difference in outcomes or complications for patients with large fibroid volumes compared to smaller fibroids. 1
• The procedure is appropriate independently of fibroid size, number, or location (including intramural fibroids). 4

Advantages Over Surgical Alternatives

Compared to myomectomy:

• UAE is equally effective at reducing heavy menstrual bleeding at 4 years. 1
• UAE has significantly lower rates of new fibroid formation than myomectomy. 1
• UAE requires shorter hospital stays and faster return to routine activities. 5
• Quality of life scores and reintervention rates at 4 years are not significantly different. 1

Compared to hysterectomy:

• UAE provides similar patient satisfaction rates while preserving the uterus. 5
• UAE avoids the long-term cardiovascular risks, mood disorders, and increased mortality associated with hysterectomy, especially at younger ages. 1

Procedure Details and Expected Outcomes

• UAE is performed under conscious sedation via transfemoral or transradial arterial approach, with both uterine arteries embolized using particulate embolic agents. 1, 2
• The procedure causes arterial occlusion, ischemic necrosis, and involution of fibroids. 1, 3
• Symptom improvement includes 83% reduction in menorrhagia, 77% improvement in dysmenorrhea, and 86% improvement in urinary frequency. 1, 2

Important Caveats and Side Effects

Common Side Effects

• Post-embolization syndrome occurs commonly and presents as flu-like symptoms with pain, nausea, fevers, and leukocytosis—this is self-limited but patients should be counseled. 1, 2
• Up to 10% of patients may require readmission for pain control. 1, 2
• Pelvic pain and vaginal expulsion of submucosal fibroids can occur (though less relevant for intramural fibroids). 1

Long-Term Considerations

• Reintervention rates are 28% at 5 years and 35% at 10 years, though most women maintain high quality-of-life scores. 1, 3, 2
• During 3-year follow-up, only 14.4% required additional procedures (9.8% repeat UAE, 2.8% myomectomy, 1.8% hysterectomy). 1, 2
• Major complications occur in <3% of patients. 1, 2

Age-Dependent Amenorrhea Risk

• For women <45 years: amenorrhea risk is <2-3%. 1, 2
• For women >45 years: amenorrhea risk increases to up to 20%. 1, 2
• This is critical counseling information based on the patient's age.

Fertility Considerations

If this patient desires future fertility, she must be counseled that:

• Pregnancy is possible after UAE, with recent prospective studies showing high live birth rates (10/12 pregnancies) and low miscarriage rates (1/12). 1
• A large retrospective cohort demonstrated a 73% live birth rate (109/148) with a 17.5% miscarriage rate. 1
• However, myomectomy may be associated with better fertility outcomes than UAE based on very low-level evidence, though this data is limited. 5
• The randomized FEMME trial found no significant difference in ovarian reserve biomarkers between UAE and myomectomy. 1

If fertility is not desired, UAE becomes even more strongly indicated as the uterine-preserving option with the best evidence base. 1, 6

Contraindications to Exclude

• Viable pregnancy must be excluded (absolute contraindication). 1
• Active pelvic inflammatory disease must be excluded (absolute contraindication). 1
• Cross-sectional imaging (preferably MRI) should confirm fibroids and exclude other pelvic pathology or underlying leiomyosarcoma. 1

Clinical Algorithm for This Patient

1. Confirm diagnosis with pelvic imaging (MRI preferred) to document fibroid characteristics and exclude malignancy. 1
2. Exclude pregnancy and active infection as absolute contraindications. 1
3. Counsel on fertility intentions: If future pregnancy desired, discuss that myomectomy may have better reproductive outcomes but UAE is still possible; if no fertility desired, UAE is strongly indicated. 1, 6, 5
4. Proceed with UAE given failed medical management and ongoing heavy bleeding. 1, 2
5. Counsel on post-embolization syndrome and pain management expectations. 1, 2
6. Follow-up at 3-6 months to assess symptom improvement and fibroid volume reduction. 1, 3